Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

105.68 +0.65 (+0.62%)
Streaming Delayed Price Updated: 2:51 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
3 Unpopular Stocks with Warning Signs
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Alex M. Azar II Joins Guardant Health Board of Directors
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
From Guardant Health, Inc.
Via Business Wire
News headline image
Earnings Scheduled For July 30, 2025 ↗
 
Via Benzinga
News headline image
Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy Stocks
News headline image
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
From Guardant Health, Inc.
Via Business Wire
News headline image
Why Guardant Health (GH) Shares Are Plunging Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 7.1% in the morning session after the company announced updated clinical results for its Shield blood-based colorectal cancer screening... 
Via StockStory
Topics Economy
News headline image
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run ↗
The company is working on a second version of its colon cancer screening test, Shield. 
Via Investor's Business Daily
News headline image
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Host Investor Day on September 24, 2025
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Cash-Burning Stocks Walking a Fine Line
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even... 
Via StockStory
Topics Bankruptcy
News headline image
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Guardant Health, Inc.
Via Business Wire
News headline image
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Initial Public Offering
News headline image
GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges
Via StockStory
News headline image
3 Russell 2000 Stocks We Keep Off Our Radar
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Discover the top movers in Thursday's pre-market session. ↗
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings ↗
Via Benzinga
News headline image
Guardant Health (GH) Q2 Revenue Up 31% ↗
Via The Motley Fool
News headline image
Guardant Health (NASDAQ:GH) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales
Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 30.9% year on year to $232.1 million. The company’s full-year revenue guidance of... 
Via StockStory
News headline image
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
From Guardant Health, Inc.
Via Business Wire
News headline image
New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health (GH) Q2 Earnings: What To Expect
Diagnostics company Guardant Health (NASDAQ:GH) will be reporting results this Wednesday after the bell. Here’s what to expect. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.